Sera from these mice contained IgG antibodies reactive with both GL261/ErbB2 and ErbB2-negative, but otherwise isogenic GL261 cells (Figure 4B), indicating that the induced protective antitumor immune response was broadly directed against the glioblastoma cells and not limited to the CAR target antigen. This evidence concerns the gene ERBB2 and glioblastoma.